PalbociclibAcquired drug resistance and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1999卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54616-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：307 / 307

相关论文

共 50 条

[21] Off-Label Drug Use in Pediatric Patients
Kimland, E.
Odlind, V.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 796 - 801
[22] Drug therapy in women: "Off-label use"?
Thuermann, Petra A.
PSYCHOPHARMAKOTHERAPIE, 2007, 14 (06): : 237 - 242
[23] Off-Label Drug Promotion and the Use of Disclaimers
McKenney, Dina
TEXAS LAW REVIEW, 2013, 92 (01) : 231 - 252
[24] Off-label use of antipsychotics: Rethinking "off-label"
Groleger, Urban
PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
[25] On-label and off-label drug use in the treatment of endometriosis
Quaas, Alexander M.
Weedin, Elizabeth A.
Hansen, Karl R.
FERTILITY AND STERILITY, 2015, 103 (03) : 612 - 625
[26] Multiple drugsLack of efficacy, drug resistance and off-label use: case report
Reactions Weekly, 2021, 1851 (1) : 242 - 242
[27] Multiple drugsLack of efficacy, drug resistance and off-label use: case report
Reactions Weekly, 2023, 1961 (1) : 290 - 290
[28] Cefepime/piperacillin/tazobactamDevelopment of drug resistance and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 192 - 192
[29] Multiple drugsLack of efficacy, drug resistance and off-label use: case report
Reactions Weekly, 2021, 1869 (1) : 247 - 247
[30] Letermovir/valganciclovirLeukopenia, off-label use and drug resistance: 2 case reports
Reactions Weekly, 2023, 1984 (1) : 298 - 298

← 1 2 3 4 5 →